Woebot Health

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, Woebot Health sits in the top decile of US sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count).

13 total trials none currently recruiting 10 completed early-phase tilt top decile by trial count

Woebot Health: 13 sponsored US clinical trials, none currently recruiting.

Woebot Health sponsors 13 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 10 completed. 0 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, Teen, with 1 trials.

Top-decile sponsor footprint

Woebot Health ranks in the top decile of sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 32/100

10 of 13 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (76.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

13 total, page 1 of 1

COMPLETED NA

Potency and Precision Investigation

NCT06240091
COMPLETED NA

Participant Satisfaction With the BUILD Mobile Application

NCT05948670
TERMINATED NA

W-PPMA for Postpartum Mothers

NCT05662605
TERMINATED NA

[Study Evaluating the Efficacy and Safety of a Digital Therapeutic as an Adjunct to TAU in Postpartum Depression]

NCT05551195
COMPLETED Phase 2

The Anchor Study: Digitally Delivered Intervention for Reducing Problematic Substance Use

NCT04925570
TERMINATED NA

Digital Therapeutic vs Educational App for Depression Among Adolescents

NCT05486611
COMPLETED NA

How Phenotypical Characteristics of Woebot Users Are Related to Clinical Outcomes

NCT05672745
COMPLETED NA

Feasibility and Acceptability of W-GenZD vs CBT-light Teletherapy for Adolescents Seeking Mental Health Services

NCT05372913
COMPLETED NA

Pilot: Digital Therapeutic vs Education for the Management of Problematic Substance Use

NCT04974645
COMPLETED NA

Digital Therapeutic vs Psychoeducation for Management of Mild to Moderate Depression in Adolescents

NCT04985331
COMPLETED NA

Pivotal Test: WB001

NCT04576754
COMPLETED Phase 1

W-SUDs for COVID-19

NCT04460027
COMPLETED Phase 1

Woebot for Substance Use Disorders

NCT04096001

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 1

Therapeutic Areas

Depression, Teen 1

How the Woebot Health early-phase archive is shaped

13 indexed studies, none listed as recruiting (0% open); 10 completed (77%).

Phase mix: 0 late (III/IV) vs 3 early (I/II) (early-phase heavy).

Top condition: Depression, Teen (1 trial), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Woebot Health: archived-pipeline peers nationwide

Peers matched on 13 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Woebot Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%2%4%6%8%10% Total trials Recruiting share Woebot HealthAdaptimmuneAgennixAkili Interactive LabsAlumis10xBio22nd Century Group23andMe3-C Institute for Social Development
Woebot Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Woebot Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 13 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Woebot Health page

13 registered trials is a research-attention snapshot, not an endorsement of Woebot Health or any single study.

  • None of Woebot Health's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Depression, Teen is the condition Woebot Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression, Teen trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Woebot Health pipeline card: 13 registered trials from official public datasets.Report a data error.